Machado, P.M. (2024) “Design and rationale for a randomized, double-blind, placebo-controlled Phase 2/3 trial of oral arimoclomol in inclusion body myositis”, RRNMF Neuromuscular Journal, 5(2). doi:10.17161/rrnmf.v4i5.16244.